Amazon Prime Video maintenant offert sur la Télé Élan
Un service télé novateur qui en offre encore plus avec l’ajout de l’appli Amazon Prime Video.Les clients de la Télé Élan […]
A.H. Belo Corporation Announces Restatement; Receives NYSE Notice Regarding Late Form 10-Q Filing
DALLAS, Nov. 20, 2019 (GLOBE NEWSWIRE) — A. H. Belo Corporation (NYSE: AHC) announced today in a Form 8-K filed […]
Mohawk Group Ranked Number 163 Fastest Growing Company in North America on Deloitte’s 2019 Technology Fast 500
Attributes 707% Revenue Growth to the Performance of its Artificial Intelligence-Driven E-Commerce Platform and Agile Supply ChainNEW YORK, Nov. 20, 2019 […]
The American College of Rheumatology Adds the Vectra® Test to List of Recommended Disease Activity Measures for Rheumatoid Arthritis
SALT LAKE CITY, Nov. 20, 2019 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics […]
Giyani Announces Grant of Stock Options
Not for distribution to U.S. newswire services or for dissemination in the United StatesOAKVILLE, Ontario, Nov. 20, 2019 (GLOBE NEWSWIRE) […]
Trevena Announces Publication of Results from Special Population Studies for Oliceridine
No dose adjustments required for patients with renal impairment or patients with mild / moderate hepatic impairmentCHESTERBROOK, Pa., Nov. 20, […]
BrainStorm Cell Therapeutics Announces Publication of NurOwn® ALS Phase 2 Randomized Clinical Trial Data in Neurology
A single transplantation of MSC-NTF cells (NurOwn®) in ALS clinical trial participants met the primary safety endpoint and demonstrated promising […]
Tonix Pharmaceuticals Announces Closing of $9.0 Million Public Offering
NEW YORK, Nov. 20, 2019 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), clinical-stage biopharmaceutical […]
Yunji to Report Third Quarter 2019 Financial Results on December 2, 2019
HANGZHOU, China, Nov. 20, 2019 (GLOBE NEWSWIRE) — Yunji Inc. (“Yunji” or the “Company”) (NASDAQ: YJ), a leading membership-based social […]
Trevena Announces Publication of Results from Phase 3 “Real World” Safety Study for Oliceridine in The Journal of Pain Research
Safety and tolerability demonstrated in diverse patient populations and surgeriesCHESTERBROOK, Pa., Nov. 20, 2019 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: […]
